Clinical trial
The Efficacy and Safety of the Modified Zhiwang Decoction Combined With Methotrexate in Early Rheumatoid Arthritis
NCT05508815 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of the Modified Zhiwang Decoction Combined With Methotrexate in Early Rheumatoid Arthritis
- Lead sponsor
- Beijing University of Chinese Medicine
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- February 9, 2023
- Completion date
- December 31, 2024
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.